-
Vancomycin hydrochloride in Resistance Assays
2026-09-15
Use Vancomycin hydrochloride as a mechanism-defined control for Gram-positive susceptibility testing, resistance profiling, and infection-model research. The workflow pairs reproducible endpoint assays with time-course measurements inspired by semi-mechanistic PKPD modeling, helping distinguish baseline reduced susceptibility from adaptive changes.
-
3-Bromopyruvate Reverses Cetuximab Resistance
2026-09-15
The reference study shows that combining 3-bromopyruvate with cetuximab can suppress intrinsically and acquired cetuximab-resistant colorectal cancer models through coordinated ferroptosis, autophagy, and apoptosis. Its mechanistic contribution is the identification of FOXO3a-dependent AMPKα/pBeclin1 and PUMA signaling as a connection between metabolic stress and multiple regulated cell-death programs.
-
HotStart qPCR Master Mix for hly RT-qPCR
2026-09-14
Translate the Listeria monocytogenes hly-deletion phenotype into a practical RT-qPCR workflow for virulence, stress-response, and quorum-sensing transcripts. The assay combines rapid hot-start amplification, inhibitor tolerance, universal ROX normalization, and melt curve confirmation for reliable dye-based results.
-
Erlotinib for EGFR–CXCR4 Signaling Studies
2026-09-14
Erlotinib (NSC 718781) provides a controlled way to test whether EGFR kinase activity contributes to receptor-complex signaling, proliferation, and apoptosis. This workflow pairs kinase inhibition with NanoBRET, proximity ligation, and cell-based readouts to distinguish EGFR catalytic dependence from ligand-driven receptor organization.
-
Cepharanthine in Endometriosis: Organoids and In Vivo
2026-09-13
A 2026 study tested Cepharanthine across immortalized stromal cells, patient-derived endometriotic cells, endometrial organoids, and a murine peritoneal model. The concordant findings link reduced lesion growth to G0/G1 arrest, DNA damage, impaired repair, and mitochondria-associated apoptosis, while highlighting organoids as a translational bridge for endometriosis drug research.
-
DAMGO Workflows for µ-Opioid Receptor Research
2026-09-12
DAMGO provides a selective way to connect µ-opioid receptor activation with membrane signaling, tissue physiology, and pain behavior. This workflow-centered guide shows how to use it to distinguish receptor-proximal effects from circuit-level opioid-induced hypersensitivity and tolerance.
-
IEM 1460: AMPA Receptor Blocker Workflows
2026-09-12
IEM 1460 enables selective dissection of AMPA-driven signaling in calcium imaging, electrophysiology, excitotoxicity, and neuronal survival assays. This practical guide translates receptor pharmacology into controlled workflows, assay controls, and troubleshooting strategies while distinguishing IEM 1460 from dual-target findings reported for IEM-1925.
-
MDM1, p53, and Chemoradiotherapy Sensitivity in CRC
2026-09-11
The 2025 Cancer Biology & Medicine study identifies MDM1 as a candidate marker of colorectal cancer chemoradiotherapy response and defines a mechanism linking MDM1 overexpression to TP53 expression, apoptosis, and treatment sensitivity. Its genetic, transcriptomic, molecular, and xenograft evidence suggests that restoring apoptotic competence may help overcome resistance in tumors with low MDM1 expression.
-
Griseofulvin: Microtubule Assay Workflows
2026-09-11
Griseofulvin enables controlled studies of fungal cell division, microtubule disruption, and concentration-dependent growth phenotypes. This workflow-oriented guide combines practical DMSO handling with a mechanistic assay framework inspired by multiparametric aneugenicity research.
-
AY 9944 dihydrochloride: Reliable DHCR7 Assays
2026-09-10
A scenario-based guide to using AY 9944 dihydrochloride (SKU A8658) for reproducible DHCR7 inhibition, sterol profiling, membrane-raft studies, and PBMC immune assays. It separates product-supported parameters from experimental recommendations and clarifies how chemical inhibition should be interpreted alongside genetic evidence.
-
NIH/3T3 Cells: Recovery, Culture, and QC
2026-09-10
NIH/3T3 Cells provide an adherent mouse fibroblast model for routine culture, cell transfection studies, viral proliferation research, and oncogene research. This guide explains recovery, expansion, assay preparation, and quality control while limiting interpretation to the product dossier and established workflow practice rather than unsupported quantitative or clinical conclusions.
-
TNF-alpha Recombinant Murine Protein in Apoptosis Assays
2026-09-09
Use TNF-alpha recombinant murine protein as a defined receptor-driven apoptosis stimulus, an inflammation model component, or an orthogonal comparator for transcription-inhibition studies. Its strong L929 cytotoxicity benchmark and controlled recombinant format support dose finding, pathway separation, and reproducible cell culture cytokine treatment.
-
n-Dodecyl-β-D-maltoside for Reliable Assays
2026-09-09
Learn how n-Dodecyl-β-D-maltoside (SKU C4421) can support membrane-protein preparation while helping researchers control detergent-related variability in viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers compatibility, optimization, interpretation, and practical vendor selection.
-
Anti-ROR1 Antibody: Applied Workflows
2026-09-08
Anti-ROR1 Antibody (Zilovertamab) combines receptor-specific binding with functional blockade for ROR1 pathway studies, making it useful across ELISA, FACS, signaling assays, and carefully qualified model systems. This guide translates the product’s specifications and a DON hepatotoxicity study into practical assay design, controls, and troubleshooting decisions.
-
EZ Cap™ Firefly Luciferase mRNA Workflow
2026-09-08
Use EZ Cap™ Firefly Luciferase mRNA to separate delivery, translation, and reporter-performance questions in cell-based assays and in vivo imaging. Its Cap1 structure and optimized poly(A) tail support sustained signal, while a recent LNP study shows why functional potency—not particle quality alone—should guide formulation decisions.